BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26243622)

  • 1. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D; El Hadi H; El Amrani M; Cabezas S; Dehbi H; Nadifi S; Quessar A; Colomer D; Moumen A; Sefrioui EL
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time quantification assay to monitor BCR-ABL1 transcripts in chronic myeloid leukemia.
    Foskett P; Gerrard G; Foroni L
    Methods Mol Biol; 2014; 1160():115-24. PubMed ID: 24740226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of
    Uzoma IC; Taiwo IA; Nna EO; Durosinmi MA; Ukaejiofo EO
    Niger J Clin Pract; 2019 Jan; 22(1):51-55. PubMed ID: 30666020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions.
    May PC; Reid AG; Robinson ME; Khorashad JS; Milojkovic D; Claudiani S; ; Willis F; Apperley JF; Innes AJ
    BMC Med Genomics; 2023 Jul; 16(1):172. PubMed ID: 37496024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.
    Martinez RJ; Kang Q; Nennig D; Bailey NG; Brown NA; Betz BL; Tewari M; Thyagarajan B; Bachanova V; Mroz P
    Arch Pathol Lab Med; 2022 Jan; 146(1):92-100. PubMed ID: 33769465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
    Brown JT; Beldorth IJ; Laosinchai-Wolf W; Fahey ME; Jefferson KL; Ruskin AK; Roth JJ; Cai L; Watt CD; Press RD; Yang F; Hedges JB; Andruss BF
    J Mol Diagn; 2019 Jul; 21(4):718-733. PubMed ID: 31026597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia.
    Moore FR; Rempfer CB; Press RD
    Methods Mol Biol; 2013; 999():1-23. PubMed ID: 23666687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
    Kjaer L; Skov V; Andersen MT; Aggerholm A; Clair P; Gniot M; Soeby K; Udby L; Dorff MH; Hasselbalch H; Pallisgaard N
    Eur J Haematol; 2019 Jul; 103(1):26-34. PubMed ID: 30985947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study.
    Sadia H; Siddiqui RT; Nasim A
    Cancer Genet Cytogenet; 2010 Aug; 201(1):57-61. PubMed ID: 20633771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
    Larripa I; Ruiz MS; Gutiérrez M; Bianchini M
    Medicina (B Aires); 2017; 77(1):61-72. PubMed ID: 28140313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
    Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
    Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the
    Stella S; Gottardi EM; Favout V; Barragan Gonzalez E; Errichiello S; Vitale SR; Fava C; Luciano L; Stagno F; Grimaldi F; Pironi L; Sargas Simarro C; Vigneri P; Izzo B
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR-ABL1 transcript types showed distinct laboratory characteristics in patients with chronic myeloid leukemia.
    Vasconcelos AP; Azevedo IF; Melo FCBC; Neves WB; Azevedo ACAC; Melo RAM
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28437552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
    Rostami G; Hamid M; Jalaeikhoo H
    Gene; 2017 Sep; 627():202-206. PubMed ID: 28627443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
    Arun AK; Senthamizhselvi A; Mani S; Vinodhini K; Janet NB; Lakshmi KM; Abraham A; George B; Srivastava A; Srivastava VM; Mathews V; Balasubramanian P
    Int J Lab Hematol; 2017 Jun; 39(3):235-242. PubMed ID: 28035733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
    White HE; Hedges J; Bendit I; Branford S; Colomer D; Hochhaus A; Hughes T; Kamel-Reid S; Kim DW; Modur V; Müller MC; Pagnano KB; Pane F; Radich J; Cross NC; Labourier E
    Clin Chem; 2013 Jun; 59(6):938-48. PubMed ID: 23471097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale.
    Seo SH; Lee SJ; Park S; Kim MJ; Song JY; Ra EK; Cho SI; Kim HK; Yang MG; Kim JY; Park SS; Seong MW
    Clin Chem Lab Med; 2016 Jul; 54(7):1157-60. PubMed ID: 26587743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
    Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
    Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.